A Phase 3, Multicenter, Open-label Safety Study to Evaluate the Long-term Safety and Tolerability of SAGE-718 in Participants with Huntington’s Disease

Monash University is providing research services under the direction of Professor Julie Stout in support of the Australian clinical trial sites participating in the clinical trial protocol 718-CIH-301. Services involve submission of the ethics application as well as ongoing ethics tasks, ie., submission of amendments, safety reports, annual reports etc.